Results 311 to 320 of about 25,999 (347)

Neuroleptic-induced ‘tardive Tourrette’s syndrome’ and neurotoxicity

1981
Neurological side effects have been associated with neuroleptic drugs since these drugs were introduced in the treatment of psychiatric disorders. Acute dystonia and parkinsonism may be seen in the initial phases of treatment while a hyperkinetic syndrome may develop later. Fauerby et al. (1964) named this late syndrome tardive dyskinesia. The frequent
R. Fog, H. Pakkenberg
openaire   +1 more source

[Neurotoxic syndrome in infectious diseases in children].

Zhurnal nevropatologii i psikhiatrii imeni S.S. Korsakova (Moscow, Russia : 1952), 1986
On the material of 72 children with infectious toxicoses the authors describe the encephalic syndrome as a manifestation of the neurotoxic syndrome. The neurotoxic syndrome was studied clinically and morphologically. A marked syndrome was characterized by a considerable edema of the brain and its stem and not infrequently by the vedging of the ...
A I, Berestov, B M, Blokhin, S S, Zhilina   +2 more
openaire   +1 more source

Immune effector cell-associated neurotoxicity syndrome (ICANS)

Vestnik nevrologii, psihiatrii i nejrohirurgii (Bulletin of Neurology, Psychiatry and Neurosurgery)
Today CAR-T-cell immunotherapy is the most advanced and promising treatment method in oncology and hematology. However, its implementation is associated with the development of severe adverse events. A significant neuropsychiatric complication associated with immunotherapy is immune effector cell-associated neurotoxicity syndrome (ICANS), previously ...
V. R. Beroeva, А. D. Tairova, I. M. Tkhamokov, M. A. Beskhlebnaya, M. I. Rustamova, D. A. Sarkisov, A. A. Zhaboev, V. G. Gorelova, S. M. Omarova   +8 more
openaire   +1 more source

Recreational Ecstasy/MDMA, the serotonin syndrome, and serotonergic neurotoxicity

Pharmacology Biochemistry and Behavior, 2002
The ring-substituted amphetamine derivative 3,4-methylenedioxymethamphetamine (MDMA) or "Ecstasy" is widely used a recreational drug. It stimulates the release and inhibits the reuptake of serotonin (5-HT) and other neurotransmitters such as dopamine to a lesser extent.
openaire   +2 more sources

Cisplatin neurotoxicity presenting as reversible posterior leukoencephalopathy syndrome.

AJNR. American journal of neuroradiology, 1998
Visual disturbance, hypertension, convulsions, and unconsciousness developed in a 70-year-old man after cisplatin chemotherapy and upper-limb amputation for osteosarcoma. MR imaging revealed bilateral reversible abnormalities in the occipital, parietal, and frontal white matter. Clinical and neuroradiologic features corresponded to reversible posterior
Y, Ito, Y, Arahata, Y, Goto, M, Hirayama, M, Nagamutsu, T, Yasuda, T, Yanagi, G, Sobue   +7 more
openaire   +1 more source

Neurotoxic effects of organophosphorus insecticides. An intermediate syndrome.

The New England journal of medicine, 1987
Acute neurotoxic effects during the cholinergic phase of organophosphorus insecticide poisoning and delayed neurotoxic effects appearing two to three weeks later are well recognized. We observed 10 patients who had paralysis of proximal limb muscles, neck flexors, motor cranial nerves, and respiratory muscles 24 to 96 hours after poisoning, after a ...
N, Senanayake, L, Karalliedde
openaire   +1 more source

Intermediate syndrome in anticholinesterase neurotoxicity

1992
Nimal Senanayake, Lakshman Karalliedde
openaire   +1 more source

A Rare Neurotoxicity Syndrome Following Opioid Intoxication

Annals of Neurology
Siddharth Venkatraman, Tej Mehta, Francis Deng   +2 more
openaire   +2 more sources

Recent progress in Lynch syndrome and other familial colorectal cancer syndromes

Ca-A Cancer Journal for Clinicians, 2018
Patrick M Boland, Matthew B Yurgelun, Clement Richard Boland   +2 more
exaly  

Specific Neurotoxic Syndromes

1998
openaire   +1 more source